Whether these structural modifications contribute to, or are a consequence of atherosclerosis is not known but, in a similar manner to what was observed with glycation phenomena in diabetic subjects [14], they might be associated with alterations of apoC1 functionality. The gene discussed is APOC1; the disease is atherosclerosis.